肺动脉高压
心脏病学
医学
生物学中的钙
钙
内科学
细胞内
药理学
化学
生物化学
作者
S. A. Mouratoglou,George Giannakoulas,Spyridon Deftereos,Γεώργιος Γιαννόπουλος,Christos Angelidis,Michael Cleman,Vassilios Vassilikos
出处
期刊:Medicinal Chemistry
[Bentham Science Publishers]
日期:2016-02-08
卷期号:12 (2): 162-169
被引量:6
标识
DOI:10.2174/157340641202160209095051
摘要
Pulmonary arterial hypertension (PAH) is a serious life threatening disease that leads to right heart failure and death. Elevated pulmonary vascular resistance (PVR) is the main pathophysiological component that leads to elevated pulmonary arterial pressures and increased right ventricular afterload. Increased PVR is related to different mechanisms that include vasoconstriction, proliferative and obstructive remodeling of the pulmonary vessel wall and in situ thrombosis. Numerous molecular, genetic and humoral abnormalities have been proposed to play an important role in pulmonary vasoconstriction and remodeling. Of those, calcium (Ca+2) is a well recognized parameter involved in the pathogenetic mechanisms of PAH, because of its twofold role in both vasoconstriction and pulmonary artery smooth muscle cell (PASMC) proliferation. The aim of this review is to focus on Ca+2 handling and dysregulation in PASMC of PAH patients. Keywords: Calcium handling, pulmonary arterial hypertension, vascular proliferation, vasoconstriction, calcium signaling, intracellular calcium handling, intercellular calcium handling.
科研通智能强力驱动
Strongly Powered by AbleSci AI